Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Radiographic Evaluation of 3Mixtatin Versus MTA Used as Pulpotomy Agents in Vital Primary Molars: A Randomized Clinical Trial

NCT06478940 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT06478940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06478940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Radiographic Evaluation of 3Mixtatin Versus MTA Used as Pulpotomy Agents in Vital Primary Molars: A Randomized Clinical Trial
Lead sponsor
Cairo University
Phase
Phase 1
Overall status
Unknown status
Start date
August 1, 2024
Completion date
September 1, 2025
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

deciduous teeth, pulp disease, dental